11/05/2024 | Press release | Distributed by Public on 11/05/2024 17:41
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Stanton Lisa M. C/O RED VIOLET, INC. 2650 N. MILITARY TRAIL, SUITE 300 BOCA RATON, FL 33431 |
X |
/s/ Lisa Stanton | 11/05/2024 |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | On November 4, 2024, the reporting person received a grant of 6,720 restricted stock units ("RSUs"), convertible into common stock of the issuer on a one-for-one basis, which vest in approximately three equal installments on each of November 1, 2025, November 1, 2026, and November 1, 2027, subject to accelerated vesting under certain conditions. The RSU grant includes an award of 3,760 RSUs for serving as a member of the Company's Board of Directors and 2,960 RSUs for serving as a member of the Audit Committee. |
(2) | Includes 5,000 RSUs originally granted on November 30, 2023, convertible into common stock of the issuer on a one-for-one basis, which vests in approximately three equal installments on each of December 1, 2024, December 1, 2025, and December 1, 2026, subject to accelerated vesting under certain conditions. |
(3) | Includes 3,335 RSUs originally granted on April 23, 2024, convertible into common stock of the issuer on a one-for-one basis, which vests 669 shares on December 1, 2024 and 1,333 shares on each of December 1, 2025, and 2026, subject to accelerated vesting under certain conditions. |
(4) | Includes 1,666 RSUs originally granted on October 12, 2022, convertible into common stock of the issuer on a one-for-one basis, which vests on November 1, 2025, subject to accelerated vesting under certain conditions. |